Staffan Nilsson

Staffan Nilsson

Auto-generated profile, based on publicly available information

Staffan Nilsson

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in EBioMedicine
Verified
Journal Article
Open access
MGMagnus Gisslén
Magnus Gisslén
RPRichard W. Price
Richard W. Price
UAUlf Andreasson
Ulf Andreasson
NNNiklas Norgren
Niklas Norgren
SNStaffan Nilsson
Staffan Nilsson
HZHenrik Zetterberg
Henrik Zetterberg
Cerebrospinal fluid (CSF) neurofilament light chain protein (NFL) is a sensitive marker of neuronal injury in a variety of neurodegenerative conditions, including the CNS dysfunction injury that is common in untreated HIV infection. However, an important limitation is the requirement for lumbar puncture. For this reason, a sensitive and reliable blood biomarker of CNS injury would represent a welcome advance in both clinical and research settings. To explore whether plasma concentrations of NFL might be used to detect CNS injury in HIV infection, an ultrasensitive Single molecule array (Simoa) immunoassay was developed. Using a cross-sectional design, we measured NFL in paired CSF and plasma samples from 121 HIV-infected subjects divided into groups according to stage of their systemic disease, presence of overt HIV-associated dementia (HAD), and after antiretroviral treatment (ART)-induced viral suppression. HIV-negative controls were also examined. Plasma and CSF NFL concentrations were very highly correlated (r = 0.89, P < 0.0001). While NFL was more than 50-fold lower plasma than CSF it was within the quantifiable range of the new plasma assay in all subjects, including the HIV negatives and the HIV positives with normal CSF NFL concentrations. The pattern of NFL changes were almost identical in plasma and CSF, both exhibiting similar age-related increases in concentrations along with highest values in HAD and substantial elevations in ART-naïve neuroasymptomatic subjects with low blood CD4(+) T cells. These results show that plasma NFL may prove a valuable tool to evaluate ongoing CNS injury in HIV infection that may be applied in the clinic and in research settings to assess the presence if active CNS injury. Because CSF NFL is also elevated in a variety of other CNS disorders, sensitive measures of plasma NFL may similarly prove useful in other settings.

15 December 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
AEArvid Edén
Arvid Edén
DFDietmar Fuchs
Dietmar Fuchs
LHLars Hagberg
Lars Hagberg
SNStaffan Nilsson
Staffan Nilsson
SSSerena Spudich
Serena Spudich
MGMagnus Gisslén
Magnus Gisslén
Background. Occasional cases of viral escape in cerebrospinal fluid (CSF) despite suppression of plasma human immunodeficiency virus type 1 (HIV-1) R

28 December 2011 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MGMagnus Gisslén
Magnus Gisslén
RPRichard W Price
Richard W Price
SNStaffan Nilsson
Staffan Nilsson
A substantial prevalence of mild neurocognitive disorders has been reported in HIV, also in patients treated with combination antiretroviral therapy (cART). This includes a new disorder that has been termed asymptomatic neurocognitive impairment (ANI).

9 February 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
HCHelena Carén
Helena Carén
HKHanna Kryh
Hanna Kryh
MNMaria Nethander
Maria Nethander
RSRose-Marie Sjöberg
Rose-Marie Sjöberg
CTCatarina Träger
Catarina Träger
TMTommy Martinsson
Tommy Martinsson
Analysis of chromosomal aberrations is used to determine the prognosis of neuroblastomas (NBs) and to aid treatment decisions. MYCN amplification (MNA) alone is an incomplete poor prognostic factor, and chromosome 11q status has recently been included in risk classification. We analyzed 165 NB tumors using high-density SNP microarrays and specifically compared the high-risk groups defined by MNA ( n = 37) and 11q-deletion ( n = 21). Median patient age at diagnosis was 21 months for MNA tumors and 42 months for 11q-deletion tumors, and median survival time after diagnosis was 16 months for MNA and 40 months for 11q deletion. Overall survival (at 8 years) was ∼35% in both groups. MNA and 11q deletion were almost mutually exclusive; only one case harbored both aberrations. The numbers of segmental aberrations differed significantly; the MNA group had a median of four aberrations, whereas the 11q-deletion group had 12. The high frequency of chromosomal breaks in the 11q-deletion group is suggestive of a chromosomal instability phenotype gene located in 11q; one such gene, H2AFX , is located in 11q23.3 (within the 11q-deletion region). Furthermore, in the groups with segmental aberrations without MNA or 11q deletion, the tumors with 17q gain have worse prognosis than those with segmental aberrations without 17q gain, which have a favorable outcome. This study has implications for therapy in different risk groups and stresses that genome-wide microarray analyses should be included in clinical management to fully evaluate risk, aid diagnosis, and guide treatment.

1 October 2008 in Transfusion
Verified
Journal Article
Closed access
PDF file
MKMartin Karlsson
Martin Karlsson
LTLisa Ternström
Lisa Ternström
MHMonica Hyllner
Monica Hyllner
FBFariba Baghaei
Fariba Baghaei
SNStaffan Nilsson
Staffan Nilsson
AJAnders Jeppsson
Anders Jeppsson

14 June 2017 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
AYAylin Yilmaz
Aylin Yilmaz
KBKaj Blennow
Kaj Blennow
LHLars Hagberg
Lars Hagberg
SNStaffan Nilsson
Staffan Nilsson
RPRichard W Price
Richard W Price
MGMagnus Gisslén
Magnus Gisslén
Introduction: Several CSF biomarkers of neuronal injury have been studied in people living with HIV. At this time, the most useful is the light subunit of the neurofilament protein (NFL). This major structural component of myelinated axons is essential to maintain axonal caliber and to facilitate effective nerve conduction. CSF concentrations of NFL provide a sensitive marker of CNS injury in a number of neurological diseases, including HIV-related neuronal injury. Areas Covered: In this review, the authors describe CSF NFL concentrations across the spectrum of HIV-infection, from its early acute phase to severe immunosuppression, with and without neurological conditions, and with and without antiretroviral treatment (n = 516). Furthermore, in order to provide more precise estimates of age-related upper limits of CSF NFL concentrations, the authors present data from a large number (n = 359) of HIV-negative controls. Expert Commentary: Recently a new ultrasensitive diagnostic assay for quantification of NFL in plasma has been developed, providing a convenient way to assess neuronal damage without having to perform a lumbar puncture. This review also considers our current knowledge of plasma NFL in HIV CNS infection.